-
Wedbush Starts Cross Country Healthcare (CCRN) at Neutral
-
Cross Country Healthcare (CCRN) Reiterated at Market Outperform by Citizens
-
UBS Reiterates Neutral Rating on Cross Country Healthcare (CCRN) as New CEO and President Announced
-
Cross Country Healthcare (CCRN) Sees a Normalized Trading Range - Citizens
-
Benchmark Reiterates Hold Rating on Cross Country Healthcare (CCRN) as Aya Cancels Merger Deal
-
Citizens Upgrades Cross Country Healthcare (CCRN) to Market Outperform
-
Cross Country Healthcare merger with Aya Healthcare terminated
-
Benchmark Reiterates Hold Rating on Cross Country Healthcare (CCRN)
-
Cross Country Healthcare (CCRN) Fairly Valued given Merger Uncertainty - Citizens
-
Cross Country Healthcare (CCRN) Fairly Valued given Merger Uncertainty - Citizens
-
Cross Country Healthcare (CCRN) Misses Q2 EPS by 8c
-
Citizens JMP Reiterates Market Perform Rating on Cross Country Healthcare (CCRN)
-
Cross Country Healthcare (CCRN) Reports In-Line Q1 EPS, Misses on Revenue
-
Citizens JMP Reiterates Market Perform Rating on Cross Country Healthcare (CCRN)
-
Cross Country Healthcare (CCRN) Misses Q4 EPS by 7c
-
Cross Country Healthcare (CCRN) PT Raised to $18.61 at Truist Securities
-
Aya Healthcare to Acquire Cross Country Healthcare (CCRN) for Approximately $615 Million in Cash
-
Cross Country Healthcare (CCRN) Tops Q3 EPS by 2c, Offers Guidance
-
The Ensign Group (ENSG) Set to Join S&P MidCap 400; Curbline Properties (CURB) & TransMedics Group (TMDX) to Join S&P SmallCap 600
-
Cross Country Healthcare (CCRN) Misses Q2 EPS by 3c ; Offers Guidance

